SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-109966
Filing Date
2018-04-06
Accepted
2018-04-06 16:09:23
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d548325ds3.htm S-3 226786
2 EX-4.6 d548325dex46.htm EX-4.6 301350
3 EX-4.7 d548325dex47.htm EX-4.7 296992
4 EX-5.1 d548325dex51.htm EX-5.1 15385
5 EX-23.1 d548325dex231.htm EX-23.1 1872
6 GRAPHIC g548325001.jpg GRAPHIC 7324
7 GRAPHIC g548325g16a80.jpg GRAPHIC 38413
  Complete submission text file 0001193125-18-109966.txt   906570
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-224180 | Film No.: 18743320
SIC: 2834 Pharmaceutical Preparations